• Publications
  • Influence
The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or diseaseExpand
  • 85
  • 8
  • Open Access
Antiviral potential of cathelicidins.
 The global burden of morbidity and mortality arising from viral infections is high; however, the development of effective therapeutics has been slow. As our understanding of innate immunity hasExpand
  • 46
  • 3
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led toExpand
  • 79
  • 2
  • Open Access